MedPath

Gusperimus

Generic Name
Gusperimus
Drug Type
Small Molecule
Chemical Formula
C17H37N7O3
CAS Number
98629-43-7
Unique Ingredient Identifier
UJ0ZJ76DO9

Overview

Gusperimus has been used in trials studying the treatment of Lupus Nephritis, Wegeners Granulomatosis, and Wegener's Granulomatosis.

Background

Gusperimus has been used in trials studying the treatment of Lupus Nephritis, Wegeners Granulomatosis, and Wegener's Granulomatosis.

Indication

短期经静脉给药用于肾移植的急性排异反应,与皮质激素或环孢素合用可增效。也可用于各种自身免疫性疾病,对风湿性关节炎、全身性红斑狼疮、肾小球肾炎有一定疗效。

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath